Filter Results
:
(512)
Show Results For
-
All HBS Web
(512)
- People (2)
- News (133)
- Research (127)
- Events (2)
- Multimedia (5)
- Faculty Publications (71)
Show Results For
-
All HBS Web
(512)
- People (2)
- News (133)
- Research (127)
- Events (2)
- Multimedia (5)
- Faculty Publications (71)
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
MS/MBA Biotechnology: Life Sciences Program will build upon students’ existing biotech and life sciences knowledge and equip them with the latest business and scientific insights. The first cohort will start in August 2020. The joint...
View Details
Keywords:
Susan Young
- Web
Women and the MBA: 6 Important Aspects of the HBS Program - MBA
Government Health Care / BioTech Manufacturing Private Equity Real Estate Retail Social Enterprise Technology Venture Capital Audiences Audiences FirstGen+ College Diverse Perspectives International LGBTQ+ Military Socioeconomic Inclusion...
View Details
- Web
There Are No HBS People, Just People Who Happen to Go to HBS - MBA
Government Health Care / BioTech Manufacturing Private Equity Real Estate Retail Social Enterprise Technology Venture Capital Audiences Audiences FirstGen+ College Diverse Perspectives International LGBTQ+ Military Socioeconomic Inclusion...
View Details
- 08 Sep 2010
- First Look
First Look: September 8, 2010
for a cure; the doubts and obstacles he experiences along the way; and the current options Kremer faces, from returning home to spend time with family to founding a new biotech venture. Through this stark, realistic, and inspiring...
View Details
Keywords:
Sean Silverthorne
- 05 Aug 2016
- News
Accelerating Change on Medicine’s Final Frontier
program had two origins: Princeton engineering lecturer James Shinn (MBA 1981) and biotech entrepreneur Gregory Stock (MBA 1987), the brother of one of Amadio’s biology professors. “They impressed upon me how interesting it would be to...
View Details
Keywords:
Robert S. Benchley
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
explore the biopharma world, so I joined L.E.K. Consulting after graduation and made my way to their Life Sciences practice. At L.E.K., I learned a tremendous amount about various pharma and biotech companies and their therapies. I worked...
View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
prescription drugs that in 1992 it spun off its remaining chemical business to its stockholders. In addition, the American Cyanamid purchase included Immunex, one of the very few biotech startups that had surpassed $100 million in...
View Details
- 01 Oct 2000
- News
The Entrepreneurial Venture
instance, who are the customers, and how do they make decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging...
View Details
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for...
View Details
Keywords:
Sean Silverthorne
- 01 Mar 2007
- News
Daniel Vasella
characterized by three things. First, we work closely with academic institutions and with biotech companies. Secondly, we created a genomics institute at The Scripps Research Institute in La Jolla, California. And the most important step...
View Details
- Web
A Eureka Moment | Social Enterprise | Harvard Business School
further.” Bucala also launched a new venture focused on healthcare, serving as CEO at MIFCOR [www.mifcortx.com], a biotech company pursuing therapies for damaged heart tissue that recently received early stage funding. “I’m the sort of...
View Details
- Web
Global Activities 2020-2021 - Global Activities 2021
Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology—to explore biotech careers in emerging markets, particularly in the Middle East and North Africa region. Her family’s difficulty obtaining health...
View Details
- 01 Sep 2014
- News
All For One
don’t know what the answer is. They have to act, not plan their way forward. Hill began to despair of finding an answer to her problem until a chance meeting with Pixar executive Greg Brandeau in the lobby of a biotech firm—Hill was there...
View Details
- 24 May 2011
- First Look
First Look: May 24
case:http://cb.hbsp.harvard.edu/cb/product/211086-PDF-ENG Innovation and Growth at Actelion Ltd Gary P. Pisano, Daniela Beyersdorfer, and Ruth DittrichHarvard Business School Case 611-065 : In late 2010, Jean-Paul Clozel, CEO of the Swiss View Details
Keywords:
Sean Silverthorne
- 25 Feb 2014
- First Look
First Look: February 25
recent firm performance? Purchase this case: http://hbr.org/product/say-on-pay-qualcomm-inc-shareholders-vote-maybe-in-2012/an/114005-PDF-ENG Harvard Business School Case 213-047 Aqua Bounty Valuation of a pre-revenue biotech company at...
View Details
Keywords:
Sean Silverthorne
- 07 Feb 2017
- First Look
First Look at New Research: February 7
case:https://cb.hbsp.harvard.edu/cbmp/product/517027-PDF-ENG Harvard Business School Case 617-022 Alnylam Pharmaceuticals: Building Value from the IP Estate (B) The leader of a pioneering biotech company in the siRNA space weighs his...
View Details
Keywords:
Sean Silverthorne
- 03 May 2011
- First Look
First Look: May 3
Business Model Gary P. Pisano, Ryan Johnson, and Carin-Isabel KnoopHarvard Business School Case 611-046 In the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this...
View Details
Keywords:
Sean Silverthorne
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety View Details
- 01 Mar 2019
- News
The Blue-Green Revolution
biotech company cofounded by genomics pioneer Craig Venter and Nobel Laureate Hamilton Smith, together with writer and life sciences investor Juan Enriquez (MBA 1986). And it may soon come to fruition: Last March, in the wake of a...
View Details
- 01 Jun 2018
- News
Up by the Roots
establishing a platform for building relationships among the relevant actors—to be a replicable model of ecosystem development that could be applied anywhere, and to any industry. (At the moment, she is attempting to strike gold twice in one place by boosting New...
View Details